Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05012930 · ClinicalTrials.gov registry record · NA

Effects of Complementary Feeding on Infant Growth and Gut Health

A NA study of Gut Microbiome and Linear Growth, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
267
Enrollment target
1
Study location

NCT05012930: Active NA study of Gut Microbiome and Linear Growth, sponsored by University of Colorado, Denver.

NCT05012930 is a NA study of Gut Microbiome and Linear Growth that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 267 participants, roughly in line with the 255-participant average among 22 other Gut Microbiome trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05012930, a NA study of Gut Microbiome and Linear Growth, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
267 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about how consuming different foods during the time of early complementary feeding (\~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut through school-age. The results from this study will potentially help to support future recommendations and dietary guidance for infant feeding practices. The three primary aims include: Aim 1. Identify the impact of dietary patterns with different protein-rich foods on infant growth. Aim 2. Identify the impact of dietary patterns with different protein-rich foods on infant gut microbiota development. Aim 3. Identify gut microbial taxa and genes that affect infant growth.

Primary Outcome

Measured in kg

Interventions

  • OTHER Baby Foods - Meat
  • OTHER Baby Foods - Dairy
  • OTHER Baby Foods - Plant
  • OTHER Foods from the home

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 267 participants
Start Date 2021-08-01
Est. Completion 2027-07
Phase NA
University of Colorado, Denver

1,283 total trials

What the registry record for NCT05012930 still lists

NCT05012930 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 255-participant average among 22 other Gut Microbiome trials with a reported enrollment target.

The record links to 2 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 4 interventions - of which Baby Foods - Meat is the first listed.

NCT05012930 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05012930 about?

NCT05012930 is a clinical study titled "Effects of Complementary Feeding on Infant Growth and Gut Health". This study plans to learn more about how consuming different foods during the time of early complementary feeding (\~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut through school-age. The results from this study will potentially help to support future re...

What is the current status of trial NCT05012930?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 267 participants. The study started on 2021-08-01. Estimated completion is 2027-07.

What conditions does trial NCT05012930 study?

This clinical trial studies the following conditions: Gut Microbiome, Linear Growth.

What interventions are being tested in trial NCT05012930?

The interventions under investigation include: Baby Foods - Meat (OTHER), Baby Foods - Dairy (OTHER), Baby Foods - Plant (OTHER), Foods from the home (OTHER).

Who is sponsoring clinical trial NCT05012930?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05012930 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gut Microbiome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05012930's enrollment target sits among peer trials

267 2nd of 22 the highest of 22 other Gut Microbiome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gut Microbiome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04997109 · 267 participants · NA

    Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

  • NCT05355701 · 267 participants · Phase 1

    A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

  • NCT06203509 · 267 participants · NA

    Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness

  • NCT05000632 · 268 participants · NA

    Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05012930, the US trial registry maintained by the National Library of Medicine. NCT05012930 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.